retatrutide and diabetes vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness A New Obesity Drug Delivered

The compounders argue a shortage still exists because the FDA acknowledged that there may still be intermittent and limited localized supply disruptions as the products move through the supply chain, while Novo has stated that supply constraints may still continue

The views expressed or information supplied through this article is mere opinion and observation of the author

Hims & Hers: GLP-1 dosing and administration Both companies prescribe GLP-1 weight-loss medications, but their approach to dosing and titration differs

Notably, a study by Finan et al

The Latest in GLP-1 Research & Innovation As a trusted name in transdermal supplementation, PatchMD remains at the forefront of scientific advancements in weight management support